Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004026875 | SCV000848873 | likely benign | Nephrolithiasis/nephrocalcinosis | 2017-01-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002060921 | SCV002321084 | benign | Lowe syndrome | 2022-10-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002493276 | SCV002800073 | likely benign | Dent disease type 2; Lowe syndrome | 2021-12-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003953272 | SCV004770031 | likely benign | OCRL-related disorder | 2019-07-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |